Intrinsic Value of S&P & Nasdaq Contact Us

Align Technology, Inc. ALGN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
$338.84
+83.5%
Analyst Price Target
$197.30
+6.8%

Align Technology, Inc. (ALGN) — Analyst outlook / Analyst consensus target is. Based on 33 analyst ratings, the consensus is bullish — 24 Buy, 7 Hold, 2 Sell.

The consensus price target is $197.30 (low: $140.00, high: $220.00), representing an upside of 6.8% from the current price $184.69.

Analysts estimate Earnings Per Share (EPS) of $9.33 and revenue of $4.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $5.63 vs est $9.33 (missed -39.7%). 2025: actual $5.66 vs est $10.20 (missed -44.5%). Analyst accuracy: 27%.

ALGN Stock — 12-Month Price Forecast

$197.30
▲ +6.83% Upside
Average Price Target
Based on 33 Wall Street analysts offering 12-month price targets for Align Technology, Inc., the average price target is $197.30, with a high forecast of $220.00, and a low forecast of $140.00.
The average price target represents a +6.83% change from the last price of $184.69.
Highest Price Target
$220.00
Average Price Target
$197.30
Lowest Price Target
$140.00

ALGN Analyst Ratings

Buy
33
Ratings
24 Buy
7 Hold
2 Sell
Based on 33 analysts giving stock ratings to Align Technology, Inc. in the past 3 months
Rating breakdown
Buy
24 73%
Hold
7 21%
Sell
2 6%
73%
Buy
24 analysts
21%
Hold
7 analysts
6%
Sell
2 analysts

EPS Estimates — ALGN

27%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $5.63 vs Est $9.33 ▼ 65.8% off
2025 Actual $5.66 vs Est $10.20 ▼ 80.2% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — ALGN

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $3.999B vs Est $4.000B ▼ 0.0% off
2025 Actual $4.035B vs Est $4.021B ▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message